Final Programme - World Heart Federation

tuesday, 20 May 2008
yangtze - oChRe Pavillion - 16:00-17:30
Clinical Seminar
undeRstanding hyPeRtRoPhiC CaRdiomyoPathy
Chairs: Lastiri Hugo (ARGENTINA), Eduardo Moreyra (ARGENTINA)
16:00 HCM in children
Alday Luis (ARGENTINA)
16:22 Pathogenesis beyond gene mutations
Matsumori Akira (JAPAN)
16:44 Missense mutations and prognosis of hypertrophic cardiomyopathy
Lorenzo Montserrat (SPAIN)
17:06 Treatment approach
Peter Liu (CANADA)
nigeR - gReen Pavillion - 16:00-17:30
Symposium
an inteRnational look at CaRe foR Patients With aCute CoRonaRy syndRome
Chairs: Mauricio Cohen (UNITED STATES), Ricardo López Santi (ARGENTINA)
16:00 EuROPE
Juan Kaski (UNITED KINGDOM)
16:18 ASIA
16:36 LATIN AMERICA
Andres Orlandini (ARGENTINA)
16:54 uSA
Leslee Shaw (UNITED STATES)
17:12 What did we learn from international registries?
P. Gabriel Steg (FRANCE)
mekong - oChRe Pavillion - 16:00-17:30
Symposium
What should be the antithRombotiC theRaPy in aCute CoRonaRy syndRome?
Chairs: Luis Mercado (BOLIVIA), P. Radke (GERMANY)
16:00 Should fondaparinux be the first choice in ACS?
Yusuf Salim (CANADA)
16:22 PCI in ACS: When to indicate and which antithrombotic agent should be used?
Enrique Fairman (ARGENTINA)
16:44 Low molecular heparin is the first choice
Robert Califf (UNITED STATES)
scientific Programme / 127